P/E at 64.83 vs Industry's 66.12: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Discount in a Premium Sector

The hospital sector is characterised by relatively high valuations, with an industry average P/E of 66.12 reflecting investor expectations of sustained growth and profitability. Apollo Hospitals Enterprise Ltd. trades at a P/E of 64.83, representing a modest discount of approximately 2% to the sector average. This suggests that while the stock is priced richly, it is not commanding a significant premium relative to its peers. The market cap of ₹1,26,819.51 crores places it firmly in the large-cap category, reinforcing its stature within the hospital sector.

This valuation positioning raises the question of whether the current price reflects the company’s fundamentals or if it is influenced by broader sector sentiment — previously rated Hold, what is Apollo Hospitals’ current rating? The slight discount to the sector P/E could indicate cautious optimism among investors, balancing growth prospects against sector-wide challenges such as regulatory pressures and rising costs.

Performance Across Timeframes: Strong Long-Term Gains Amid Mixed Short-Term Signals

Examining Apollo Hospitals Enterprise Ltd.’s returns reveals a compelling long-term growth story. Over the past 10 years, the stock has surged by 548.73%, vastly outperforming the Sensex’s 184.20% gain. Similarly, the five-year return of 116.85% and three-year return of 77.09% underscore sustained outperformance.

However, the short-term momentum is more mixed. The stock’s 3-month return of 13.98% outpaces the Sensex’s 1.94%, but the one-month and one-week performances show declines of 0.87% and 0.97% respectively, while the Sensex gained 1.29% and 2.60% over the same periods. The one-day performance is flat at 0.00%, compared to the Sensex’s 0.16% rise. This divergence suggests some recent profit-taking or sector rotation — is this a temporary pause or a sign of shifting investor sentiment?

Moving Average Configuration: Signs of a Consolidation Phase

The technical picture for Apollo Hospitals Enterprise Ltd. reveals a nuanced trend. The stock is trading above its 50-day, 100-day, and 200-day moving averages, indicating a solid medium to long-term uptrend. However, it remains below its 5-day and 20-day moving averages, reflecting recent short-term weakness or consolidation.

This configuration often signals a pause or minor pullback within a broader upward trend. The stock’s recent gain after two consecutive days of decline suggests some resilience, but the inability to surpass the short-term moving averages points to cautious trading activity — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Performance and Trends

The hospital sector has experienced mixed results recently, with some companies reporting strong earnings growth while others face margin pressures due to rising input costs and regulatory changes. The sector’s average P/E of 66.12 reflects elevated expectations, but also heightened sensitivity to operational risks.

Within this environment, Apollo Hospitals Enterprise Ltd.’s ability to maintain a P/E close to the sector average while delivering strong long-term returns is notable. The stock’s large-cap status and diversified operations provide some insulation against sector volatility, but the recent short-term underperformance relative to the Sensex highlights ongoing challenges — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Hold. The previous Mojo Score stood at 75.0, reflecting a positive but cautious outlook. This reassessment aligns with the company’s strong long-term performance and valuation metrics that remain in line with the sector.

The rating update invites investors to reanalyse the stock’s fundamentals and technicals in light of recent market developments — what is the current rating? The balance between valuation premium and performance consistency remains a key consideration.

Conclusion: A Balanced Valuation and Performance Profile

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation slightly below its sector average, supported by robust long-term returns. The short-term performance and moving average configuration suggest a phase of consolidation rather than a clear breakout or breakdown.

Investors weighing the stock must consider the interplay between its premium valuation environment and the recent mixed momentum — does the current rating reflect these dynamics adequately? The reassessment from a previous Hold rating underscores the importance of ongoing analysis in a sector marked by both opportunity and risk.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today